ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-15R8590
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Nonsteroidal Antiinflammatory Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025

Code: QYRE-Auto-15R8590
Report
January 2025
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Novartis
GlaxoSmithKline PLC
Pfizer Inc
DOMESCO

Nonsteroidal Antiinflammatory Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Nonsteroidal Antiinflammatory Drugs Market

Nonsteroidal Antiinflammatory Drugs Market

The global market for Nonsteroidal Antiinflammatory Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Non-steroidal anti-inflammatory drugs refer to a class of drugs that do not contain glucocorticoids and have anti-inflammatory, antipyretic and analgesic effects. It is a first-line drug for the treatment of osteoarthritis and is widely used in other bone and joint diseases, rheumatic and immune diseases and pain diseases.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nonsteroidal Antiinflammatory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonsteroidal Antiinflammatory Drugs.
The Nonsteroidal Antiinflammatory Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nonsteroidal Antiinflammatory Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nonsteroidal Antiinflammatory Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nonsteroidal Antiinflammatory Drugs Market Report

Report Metric Details
Report Name Nonsteroidal Antiinflammatory Drugs Market
CAGR 5%
Segment by Type
Segment by Application
  • Osteoarthritis
  • Muscle Aches
  • Backaches
  • Dental Pain
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Pfizer, DOMESCO
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nonsteroidal Antiinflammatory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nonsteroidal Antiinflammatory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Nonsteroidal Antiinflammatory Drugs Market report?

Ans: The main players in the Nonsteroidal Antiinflammatory Drugs Market are Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Pfizer, DOMESCO

What are the Application segmentation covered in the Nonsteroidal Antiinflammatory Drugs Market report?

Ans: The Applications covered in the Nonsteroidal Antiinflammatory Drugs Market report are Osteoarthritis, Muscle Aches, Backaches, Dental Pain, Others

What are the Type segmentation covered in the Nonsteroidal Antiinflammatory Drugs Market report?

Ans: The Types covered in the Nonsteroidal Antiinflammatory Drugs Market report are Oral Nonsteroidal Antiinflammatory Drugs, Injection Nonsteroidal Antiinflammatory Drugs

Recommended Reports

Antiinflammatory Drugs

Musculoskeletal Treatments

Therapeutic Drugs Markets

1 Nonsteroidal Antiinflammatory Drugs Market Overview
1.1 Product Definition
1.2 Nonsteroidal Antiinflammatory Drugs by Type
1.2.1 Global Nonsteroidal Antiinflammatory Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Nonsteroidal Antiinflammatory Drugs
1.2.3 Injection Nonsteroidal Antiinflammatory Drugs
1.3 Nonsteroidal Antiinflammatory Drugs by Application
1.3.1 Global Nonsteroidal Antiinflammatory Drugs Market Value by Application (2024 VS 2031)
1.3.2 Osteoarthritis
1.3.3 Muscle Aches
1.3.4 Backaches
1.3.5 Dental Pain
1.3.6 Others
1.4 Global Nonsteroidal Antiinflammatory Drugs Market Size Estimates and Forecasts
1.4.1 Global Nonsteroidal Antiinflammatory Drugs Revenue 2020-2031
1.4.2 Global Nonsteroidal Antiinflammatory Drugs Sales 2020-2031
1.4.3 Global Nonsteroidal Antiinflammatory Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nonsteroidal Antiinflammatory Drugs Market Competition by Manufacturers
2.1 Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nonsteroidal Antiinflammatory Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nonsteroidal Antiinflammatory Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nonsteroidal Antiinflammatory Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nonsteroidal Antiinflammatory Drugs, Product Type & Application
2.7 Global Key Manufacturers of Nonsteroidal Antiinflammatory Drugs, Date of Enter into This Industry
2.8 Global Nonsteroidal Antiinflammatory Drugs Market Competitive Situation and Trends
2.8.1 Global Nonsteroidal Antiinflammatory Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nonsteroidal Antiinflammatory Drugs Players Market Share by Revenue
2.8.3 Global Nonsteroidal Antiinflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nonsteroidal Antiinflammatory Drugs Market Scenario by Region
3.1 Global Nonsteroidal Antiinflammatory Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nonsteroidal Antiinflammatory Drugs Sales by Region: 2020-2031
3.2.1 Global Nonsteroidal Antiinflammatory Drugs Sales by Region: 2020-2025
3.2.2 Global Nonsteroidal Antiinflammatory Drugs Sales by Region: 2026-2031
3.3 Global Nonsteroidal Antiinflammatory Drugs Revenue by Region: 2020-2031
3.3.1 Global Nonsteroidal Antiinflammatory Drugs Revenue by Region: 2020-2025
3.3.2 Global Nonsteroidal Antiinflammatory Drugs Revenue by Region: 2026-2031
3.4 North America Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Country
3.4.1 North America Nonsteroidal Antiinflammatory Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2031)
3.4.3 North America Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Country
3.5.1 Europe Nonsteroidal Antiinflammatory Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2031)
3.5.3 Europe Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Nonsteroidal Antiinflammatory Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Country
3.7.1 Latin America Nonsteroidal Antiinflammatory Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2031)
3.7.3 Latin America Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nonsteroidal Antiinflammatory Drugs Sales by Type (2020-2031)
4.1.1 Global Nonsteroidal Antiinflammatory Drugs Sales by Type (2020-2025)
4.1.2 Global Nonsteroidal Antiinflammatory Drugs Sales by Type (2026-2031)
4.1.3 Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2020-2031)
4.2 Global Nonsteroidal Antiinflammatory Drugs Revenue by Type (2020-2031)
4.2.1 Global Nonsteroidal Antiinflammatory Drugs Revenue by Type (2020-2025)
4.2.2 Global Nonsteroidal Antiinflammatory Drugs Revenue by Type (2026-2031)
4.2.3 Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Nonsteroidal Antiinflammatory Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2031)
5.1.1 Global Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025)
5.1.2 Global Nonsteroidal Antiinflammatory Drugs Sales by Application (2026-2031)
5.1.3 Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2020-2031)
5.2 Global Nonsteroidal Antiinflammatory Drugs Revenue by Application (2020-2031)
5.2.1 Global Nonsteroidal Antiinflammatory Drugs Revenue by Application (2020-2025)
5.2.2 Global Nonsteroidal Antiinflammatory Drugs Revenue by Application (2026-2031)
5.2.3 Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Nonsteroidal Antiinflammatory Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi S.A.
6.1.1 Sanofi S.A. Company Information
6.1.2 Sanofi S.A. Description and Business Overview
6.1.3 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Product Portfolio
6.1.5 Sanofi S.A. Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Company Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis AG Nonsteroidal Antiinflammatory Drugs Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 GlaxoSmithKline PLC
6.3.1 GlaxoSmithKline PLC Company Information
6.3.2 GlaxoSmithKline PLC Description and Business Overview
6.3.3 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Product Portfolio
6.3.5 GlaxoSmithKline PLC Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Nonsteroidal Antiinflammatory Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 DOMESCO
6.5.1 DOMESCO Company Information
6.5.2 DOMESCO Description and Business Overview
6.5.3 DOMESCO Nonsteroidal Antiinflammatory Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 DOMESCO Nonsteroidal Antiinflammatory Drugs Product Portfolio
6.5.5 DOMESCO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nonsteroidal Antiinflammatory Drugs Industry Chain Analysis
7.2 Nonsteroidal Antiinflammatory Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nonsteroidal Antiinflammatory Drugs Production Mode & Process Analysis
7.4 Nonsteroidal Antiinflammatory Drugs Sales and Marketing
7.4.1 Nonsteroidal Antiinflammatory Drugs Sales Channels
7.4.2 Nonsteroidal Antiinflammatory Drugs Distributors
7.5 Nonsteroidal Antiinflammatory Drugs Customer Analysis
8 Nonsteroidal Antiinflammatory Drugs Market Dynamics
8.1 Nonsteroidal Antiinflammatory Drugs Industry Trends
8.2 Nonsteroidal Antiinflammatory Drugs Market Drivers
8.3 Nonsteroidal Antiinflammatory Drugs Market Challenges
8.4 Nonsteroidal Antiinflammatory Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
Novartis
GlaxoSmithKline PLC
Pfizer Inc
DOMESCO
List of Tables
 Table 1. Global Nonsteroidal Antiinflammatory Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nonsteroidal Antiinflammatory Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nonsteroidal Antiinflammatory Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nonsteroidal Antiinflammatory Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nonsteroidal Antiinflammatory Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nonsteroidal Antiinflammatory Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nonsteroidal Antiinflammatory Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nonsteroidal Antiinflammatory Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nonsteroidal Antiinflammatory Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Nonsteroidal Antiinflammatory Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nonsteroidal Antiinflammatory Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonsteroidal Antiinflammatory Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nonsteroidal Antiinflammatory Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nonsteroidal Antiinflammatory Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Nonsteroidal Antiinflammatory Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Nonsteroidal Antiinflammatory Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Nonsteroidal Antiinflammatory Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Nonsteroidal Antiinflammatory Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Nonsteroidal Antiinflammatory Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nonsteroidal Antiinflammatory Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nonsteroidal Antiinflammatory Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Nonsteroidal Antiinflammatory Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nonsteroidal Antiinflammatory Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nonsteroidal Antiinflammatory Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Nonsteroidal Antiinflammatory Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nonsteroidal Antiinflammatory Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Nonsteroidal Antiinflammatory Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nonsteroidal Antiinflammatory Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Nonsteroidal Antiinflammatory Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Nonsteroidal Antiinflammatory Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Nonsteroidal Antiinflammatory Drugs Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Nonsteroidal Antiinflammatory Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nonsteroidal Antiinflammatory Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Nonsteroidal Antiinflammatory Drugs Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Nonsteroidal Antiinflammatory Drugs Price (USD/Pcs) by Application (2026-2031)
 Table 70. Sanofi S.A. Company Information
 Table 71. Sanofi S.A. Description and Business Overview
 Table 72. Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Product
 Table 74. Sanofi S.A. Recent Developments/Updates
 Table 75. Novartis AG Company Information
 Table 76. Novartis AG Description and Business Overview
 Table 77. Novartis AG Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Novartis AG Nonsteroidal Antiinflammatory Drugs Product
 Table 79. Novartis AG Recent Developments/Updates
 Table 80. GlaxoSmithKline PLC Company Information
 Table 81. GlaxoSmithKline PLC Description and Business Overview
 Table 82. GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Product
 Table 84. GlaxoSmithKline PLC Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Pfizer Nonsteroidal Antiinflammatory Drugs Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. DOMESCO Company Information
 Table 91. DOMESCO Description and Business Overview
 Table 92. DOMESCO Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. DOMESCO Nonsteroidal Antiinflammatory Drugs Product
 Table 94. DOMESCO Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Nonsteroidal Antiinflammatory Drugs Distributors List
 Table 98. Nonsteroidal Antiinflammatory Drugs Customers List
 Table 99. Nonsteroidal Antiinflammatory Drugs Market Trends
 Table 100. Nonsteroidal Antiinflammatory Drugs Market Drivers
 Table 101. Nonsteroidal Antiinflammatory Drugs Market Challenges
 Table 102. Nonsteroidal Antiinflammatory Drugs Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nonsteroidal Antiinflammatory Drugs
 Figure 2. Global Nonsteroidal Antiinflammatory Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nonsteroidal Antiinflammatory Drugs Market Share by Type: 2024 & 2031
 Figure 4. Oral Nonsteroidal Antiinflammatory Drugs Product Picture
 Figure 5. Injection Nonsteroidal Antiinflammatory Drugs Product Picture
 Figure 6. Global Nonsteroidal Antiinflammatory Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Nonsteroidal Antiinflammatory Drugs Market Share by Application: 2024 & 2031
 Figure 8. Osteoarthritis
 Figure 9. Muscle Aches
 Figure 10. Backaches
 Figure 11. Dental Pain
 Figure 12. Others
 Figure 13. Global Nonsteroidal Antiinflammatory Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Nonsteroidal Antiinflammatory Drugs Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Nonsteroidal Antiinflammatory Drugs Sales (2020-2031) & (K Pcs)
 Figure 16. Global Nonsteroidal Antiinflammatory Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 17. Nonsteroidal Antiinflammatory Drugs Report Years Considered
 Figure 18. Nonsteroidal Antiinflammatory Drugs Sales Share by Manufacturers in 2024
 Figure 19. Global Nonsteroidal Antiinflammatory Drugs Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Nonsteroidal Antiinflammatory Drugs Players: Market Share by Revenue in Nonsteroidal Antiinflammatory Drugs in 2024
 Figure 21. Nonsteroidal Antiinflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Nonsteroidal Antiinflammatory Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2020-2031)
 Figure 24. North America Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2020-2031)
 Figure 28. Europe Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region (2020-2031)
 Figure 36. China Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Nonsteroidal Antiinflammatory Drugs by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Nonsteroidal Antiinflammatory Drugs by Type (2020-2031)
 Figure 58. Global Nonsteroidal Antiinflammatory Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Nonsteroidal Antiinflammatory Drugs by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Nonsteroidal Antiinflammatory Drugs by Application (2020-2031)
 Figure 61. Global Nonsteroidal Antiinflammatory Drugs Price (USD/Pcs) by Application (2020-2031)
 Figure 62. Nonsteroidal Antiinflammatory Drugs Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030
Global Nonsteroidal Anti Inflammatory Drugs NSAIDs Market Research Report 2024
Non steroidal Anti inflammatory Drugs NSAID Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Topical Non Steroidal Anti Inflammatory Drugs Market Research Report 2024
Non Steroidal Anti Inflammatory Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dermatological Non Steroidal Anti Inflammatory Drugs Market Research Report 2024
Global Antiinflammatory Drugs Market Insights Forecast to 2030
Orthopedics Nonsteroidal Anti Inflammatory Drugs NSAIDs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Narcotic Analgesics Market Research Report 2025
Global Pet NSAIDs Market Research Report 2025
Global Nonnarcotic Analgesics Market Research Report 2025
Global Non Steroidal Anti Inflammatory API Market Research Report 2025
Global Nonsteroidal Anti inflammatory APIs Market Research Report 2024
Global Loxoprofen Market Research Report 2024
Global Pets NSAIDs Market Research Report 2025
Global Tenoxicam Market Research Report 2024
Global Non opioid Analgesics Market Research Report 2024
Global NSAIDs Market Research Report 2025
Global Cyclooxygenase 2 Inhibitor Market Research Report 2024
Medicine for Osteoarthritis Pain Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions